132 related articles for article (PubMed ID: 19793519)
1. The REGICOR-calibrated function provides a better classification of high-risk patients on statin treatment in the Spanish population than the Framingham or SCORE classifications.
Baena-Díez JM; Grau M; Sánchez-Pérez R; Altes-Vaques E; Salas-Gaetjens LH; Hernández-Ibáñez MR
Rev Esp Cardiol; 2009 Oct; 62(10):1134-40. PubMed ID: 19793519
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of the SCORE and REGICOR models for calculating cardiovascular risk in cardiovascular disease-free individuals at a healthcare center in Barcelona, Spain].
Baena Díez JM; del Val Garcia JL; Héctor Salas Gaetgens L; Sánchez Pérez R; Altes Vaques E; Deixens Martínez B; Amatller Corominas M; Katia Núñez Casillas D
Rev Esp Salud Publica; 2005; 79(4):453-64. PubMed ID: 16465962
[TBL] [Abstract][Full Text] [Related]
3. [Agreement between REGICOR and SCORE scales in identifying high cardiovascular risk in the Spanish population].
Gil-Guillén V; Orozco-Beltrán D; Maiques-Galán A; Aznar-Vicente J; Navarro J; Cea-Calvo L; Quirce-Andrés F; Redón J; Merino-Sánchez J
Rev Esp Cardiol; 2007 Oct; 60(10):1042-50. PubMed ID: 17953925
[TBL] [Abstract][Full Text] [Related]
4. [Predictive capacity, comparison and clinic consequences of the Framingham-Wilson and REGICOR tables in persons for whom care has been provided at a health care center, Badajoz, Spain].
Cañón Barroso L; Díaz Herrera N; Cruces Muro E; Nieto Hernández T; Garrote Florencio T; Buitrago F
Rev Esp Salud Publica; 2007; 81(4):353-64. PubMed ID: 18041538
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of the REGICOR and SCORE function charts for classifying cardiovascular risk and for selecting patients for hypolipidemic or antihypertensive treatment].
Buitrago F; Cañón-Barroso L; Díaz-Herrera N; Cruces-Muro E; Escobar-Fernández M; Serrano-Arias JM
Rev Esp Cardiol; 2007 Feb; 60(2):139-47. PubMed ID: 17338879
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of the SCORE function chart and the Framingham-REGICOR equation to estimate the cardiovascular risk in an urban population after 10 years of follow-up].
Buitrago Ramírez F; Cañón Barroso L; Díaz Herrera N; Cruces Muro E; Bravo Simón B; Pérez Sánchez I
Med Clin (Barc); 2006 Sep; 127(10):368-73. PubMed ID: 16987481
[TBL] [Abstract][Full Text] [Related]
7. The Framingham function overestimates the risk of ischemic heart disease in HIV-infected patients from Barcelona.
Herrera S; Guelar A; Sorlì L; Vila J; Molas E; Grau M; Marrugat J; Esteve E; Güerri-Fernández R; Montero M; Knobel H
HIV Clin Trials; 2016 Jul; 17(4):131-9. PubMed ID: 27169692
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of population coronary heart disease risk estimated by the Framingham original and REGICOR calibrated functions].
Ramos R; Solanas P; Cordón F; Rohlfs I; Elosua R; Sala J; Masiá R; Faixedas MT; Marrugat J
Med Clin (Barc); 2003 Oct; 121(14):521-6. PubMed ID: 14599406
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).
Khera AV; Demler OV; Adelman SJ; Collins HL; Glynn RJ; Ridker PM; Rader DJ; Mora S
Circulation; 2017 Jun; 135(25):2494-2504. PubMed ID: 28450350
[TBL] [Abstract][Full Text] [Related]
10. [Validation of 3 equations of coronary risk in diabetic population of a primary care center].
Cañón-Barroso L; Cruces-Muro E; Fernández-Ochoa G; Nieto-Hernández T; García-Vellido A; Buitrago F
Med Clin (Barc); 2006 Apr; 126(13):485-90. PubMed ID: 16624226
[TBL] [Abstract][Full Text] [Related]
11. [Carotid intima-media thickness distribution according to the stratification of cardiovascular risk by means of Framingham-REGICOR and score function charts].
Hermida-Ameijeiras Á; López-Paz JE; Riveiro-Cruz MA; Calvo-Gómez C
Hipertens Riesgo Vasc; 2016; 33(2):51-7. PubMed ID: 26796100
[TBL] [Abstract][Full Text] [Related]
12. Original and REGICOR Framingham functions in a nondiabetic population of a Spanish health care center: a validation study.
Buitrago F; Calvo-Hueros JI; Cañón-Barroso L; Pozuelos-Estrada G; Molina-Martínez L; Espigares-Arroyo M; Galán-González JA; Lillo-Bravo FJ
Ann Fam Med; 2011; 9(5):431-8. PubMed ID: 21911762
[TBL] [Abstract][Full Text] [Related]
13. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
Querton L; Buysschaert M; Hermans MP
J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of coronary risk estimates derived using the Framingham and REGICOR equations].
Cristóbal J; Lago F; de la Fuente J; González-Juanatey JR; Vázquez-Bellés P; Vila M
Rev Esp Cardiol; 2005 Aug; 58(8):910-5. PubMed ID: 16053824
[TBL] [Abstract][Full Text] [Related]
15. Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.
Pursnani A; Massaro JM; D'Agostino RB; O'Donnell CJ; Hoffmann U
JAMA; 2015 Jul; 314(2):134-41. PubMed ID: 26172893
[TBL] [Abstract][Full Text] [Related]
16. On-treatment C-reactive protein and HDL cholesterol levels in patients at intermediate cardiovascular risk: impact on carotid intima-media thickness.
Pirro M; Vaudo G; Lupattelli G; Pasqualini L; Mannarino MR; Schillaci G; Alaeddin A; Paciullo F; Fallarino F; Bagaglia F; Mannarino E
Life Sci; 2013 Sep; 93(8):338-43. PubMed ID: 23871987
[TBL] [Abstract][Full Text] [Related]
17. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.
Akhabue E; Rittner SS; Carroll JE; Crawford PM; Dant L; Laws R; Leo MC; Puro J; Persell SD
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673901
[TBL] [Abstract][Full Text] [Related]
18. Intensity of statin therapy, achieved low-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after coronary revascularization. Perspectives from the CREDO-Kyoto registry cohort-2.
Natsuaki M; Furukawa Y; Morimoto T; Nakagawa Y; Ono K; Kaburagi S; Inada T; Mitsuoka H; Taniguchi R; Nakano A; Kita T; Sakata R; Kimura T;
Circ J; 2012; 76(6):1369-79. PubMed ID: 22447012
[TBL] [Abstract][Full Text] [Related]
19. Cross-sectional analysis of the prevalence and predictors of statin utilisation in Ireland with a focus on primary prevention of cardiovascular disease.
Byrne P; Cullinan J; Murphy C; Smith SM
BMJ Open; 2018 Feb; 8(2):e018524. PubMed ID: 29439070
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis: statin therapy does not alter the association between low levels of high-density lipoprotein cholesterol and increased cardiovascular risk.
Jafri H; Alsheikh-Ali AA; Karas RH
Ann Intern Med; 2010 Dec; 153(12):800-8. PubMed ID: 21173414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
